Medadvisor Ltd
ASX:MDR
Intrinsic Value
MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. [ Read More ]
The intrinsic value of one MDR stock under the Base Case scenario is 0.243 AUD. Compared to the current market price of 0.275 AUD, Medadvisor Ltd is Overvalued by 12%.
Valuation Backtest
Medadvisor Ltd
Run backtest to discover the historical profit from buying and selling MDR stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Medadvisor Ltd
Current Assets | 28.1m |
Cash & Short-Term Investments | 14.3m |
Receivables | 11.7m |
Other Current Assets | 2.1m |
Non-Current Assets | 67.8m |
PP&E | 1.4m |
Intangibles | 66.4m |
Other Non-Current Assets | 17.1k |
Current Liabilities | 33.2m |
Accounts Payable | 4.2m |
Accrued Liabilities | 5.6m |
Other Current Liabilities | 23.4m |
Non-Current Liabilities | 14.3m |
Long-Term Debt | 12.3m |
Other Non-Current Liabilities | 2m |
Earnings Waterfall
Medadvisor Ltd
Revenue
|
109.4m
AUD
|
Cost of Revenue
|
-45m
AUD
|
Gross Profit
|
64.4m
AUD
|
Operating Expenses
|
-70.5m
AUD
|
Operating Income
|
-6m
AUD
|
Other Expenses
|
-3m
AUD
|
Net Income
|
-9m
AUD
|
Free Cash Flow Analysis
Medadvisor Ltd
What is Free Cash Flow?
MDR Profitability Score
Profitability Due Diligence
Medadvisor Ltd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
Score
Medadvisor Ltd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
MDR Solvency Score
Solvency Due Diligence
Medadvisor Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Score
Medadvisor Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MDR Price Targets Summary
Medadvisor Ltd
According to Wall Street analysts, the average 1-year price target for MDR is 0.411 AUD with a low forecast of 0.384 AUD and a high forecast of 0.462 AUD.
Shareholder Return
MDR Price
Medadvisor Ltd
Average Annual Return | -27.17% |
Standard Deviation of Annual Returns | 41.75% |
Max Drawdown | -100% |
Market Capitalization | 151.2m AUD |
Shares Outstanding | 549 866 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-05-26. The firm is engaged in the development and delivering software for personal medication management. The Company’s products include MedAdvisor App, PlusOne pharmacy platform. MedAdvisor App and its supporting software platform provides individuals and minders to manage all aspects of prescription medication use. Its cloud-based medication records and data connects pharmacies and other HCPs. The firm provides pharmaceutical health program..
Contact
IPO
Employees
Officers
The intrinsic value of one MDR stock under the Base Case scenario is 0.243 AUD.
Compared to the current market price of 0.275 AUD, Medadvisor Ltd is Overvalued by 12%.